WellBrain, Founded by 3 Harvard, Stanford, and Mayo Clinic Trained Physicians, Expands Its Reach as One of the Largest Clinically-Validated, Digital Chronic Pain Management and Addiction Prevention Tools With Recent Mevoked Acquisition

Press Release (ePRNews.com) - PLEASANT HILL, Calif. - Aug 16, 2018 - WellBrain, the bay area’s pioneering personalized addiction prevention and chronic pain management platform that is helping fight the opioid epidemic, has announced yesterday that they have expanded their toolset through the acquisition of Mevoked.

Mevoked has developed an online and mobile data analytics tool that correlates technology use with behavior. Mevoked’s first product leverages this analytics to help support women and prevent, treat, and manage, perinatal/postpartum depression and anxiety. Beyond pregnancy, other use cases in development focus on supporting patients in cancer treatment and diabetes.

Arun Ravi, CEO and Co-Founder of Mevoked is excited about the acquisition and said “WellBrain offers us the best opportunity to accelerate the technology development and applicability in a very demanding space. I look forward to seeing what WellBrain will do with Mevoked’s patent-pending technology and being a part of that vision!”

By joining forces, WellBrain, founded by 3 Harvard, Stanford, and Mayo Clinic trained physicians, expand its reach as one of the largest clinically-validated, digital chronic pain management and addiction prevention tools and now helps more than 30,000 patients monthly across 18 states.

Read more about their acquisition at www.wellbrain.io and read more about Mevoked at www.mevoked.com and see why founder, Dr. Ruben Kalra, M.D. and CEO, Sumeet Maniar see the move as helping build “the most powerful, AI/ML and data-driven addiction prevention and chronic pain management tool on the market.”

For more info use: info@WellBrain.io

Source : WellBrain
Business Info :

You may also like this  


Or using ePRNews Account

Don't have an account ? Sign Up

Register New Account

Already have an account ? Login

Reset Password

Already have an account ? Login


If you have any concerns regarding this press release, please contact the Author / Media Contact / Business of this press release. ePRNews is not resposible for the accuracy of the news posted and do not endorse, support any product/ services/ business mentioned and hereby disclaims any content contained in this press release.